In our study, although BMI in PCOS patients were much higher than the control group, the comparison of ANGPTL4 expression among normal-weight and overweight patients showed no difference in both the PCOS group and control group in Table 3. This evidence concerns the gene ANGPTL4 and polycystic ovary syndrome.